Printer Friendly

Fly Intel: Pre-market Movers.

HIGHER: Intra-Cellular (ITCI), up 3% after announcing that it recently met with the FDA and reached agreement to submit additional non-clinical information in connection with the FDA's ongoing review of the company's new drug application, or NDA, for lumateperone for the treatment of schizophrenia... Allakos (ALLK), up 94% after reporting results from its placebo-controlled trial of AK002 in patients with eosinophilic gastritis and/or eosinophilic gastroenteritis. All AK002 dose arms showed clinically meaningful and statistically significant benefits compared to placebo on all prespecified primary and secondary endpoints, including gastrointestinal tissue eosinophil counts and patient reported disease symptoms. UP AFTER EARNINGS: Delek US (DK), up 1%... Linde plc (LIN), up 1%... Sapiens (SPNS), up 2%. DOWN AFTER EARNINGS: (SOHU), down 6%... Diamond Offshore (DO), down 16%... On Semiconductor (ON), down 7%... (CYOU), down 5%. ALSO LOWER: (CARS), down 33% after concluding strategic review process with no actionable bids... GlycoMimetics (GLYC), down 56% after reporting that Pfizer (PFE) announced that the Phase 3 Rivipansel Evaluating Safety, Efficacy and Time to Discharge, or RESET, pivotal study did not meet its primary or key secondary efficacy endpoints... HSBC (HSBC), down 2% after announcing CEO John Flint stepped down.

COPYRIGHT 2019 The Fly
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2019 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:The Fly
Article Type:Clinical report
Date:Aug 5, 2019
Previous Article:Digital Ally announces partnership with KMC Brands.
Next Article:Celsion announces data lock for interim analysis in OPTIMA Phase III study.

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |